LncRNA-mRNA Co-expression Profiles Relative to Vascular Remodeling in Moyamoya Patients Without RNF213 Mutation

Jinbing Zhao1, Cheng Qiu1, Guangxu Zhang1

  • 1Nanjing Comprehensive Stroke Center, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, PR China.

World Neurosurgery
|December 1, 2021
PubMed
Abstract

Insights

This study reveals novel long noncoding RNA and messenger RNA profiles in Moyamoya disease (MMD) patients, identifying WNT5A as a key factor in vascular remodeling and potential therapeutic target for MMD angiogenesis.

Area of Science:

  • Genomics and Molecular Biology
  • Vascular Biology
  • Cerebrovascular Diseases

Background:

  • Moyamoya disease (MMD) is a rare cerebrovascular disorder with unknown causes.
  • The roles of long noncoding RNAs (lncRNAs) and messenger RNAs (mRNAs) in MMD pathogenesis are not well understood.

Purpose of the Study:

  • To investigate the lncRNA-mRNA co-expression patterns and their functional significance in the superficial temporal artery (STA) of MMD patients.
  • To identify potential molecular mechanisms and therapeutic targets involved in MMD-related vascular remodeling.

Main Methods:

  • Transcriptomic RNA sequencing of STA from MMD patients and controls.
  • Bioinformatics analysis for lncRNA-mRNA co-expression networks and functional enrichment.
  • Validation of differentially expressed genes and WNT5A function in endothelial cells.

Main Results:

  • Identified 6235 differentially expressed lncRNAs and 2065 mRNAs between MMD patients and controls.
  • Altered mRNAs were enriched in pathways related to endothelial cell morphogenesis and angiogenesis.
  • WNT5A, TEK, and GATA2 were implicated in MMD vascular malformation, with WNT5A promoting endothelial cell functions.

Conclusions:

  • Aberrant disruption of vascular remodeling genes, including WNT5A, occurs in MMD patients.
  • These findings provide insights into MMD pathogenesis and suggest potential therapeutic targets for promoting angiogenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
78
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
155
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
475